首页> 美国卫生研究院文献>World Journal of Gastroenterology >Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma
【2h】

Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma

机译:STAT4的减少表明肝细胞癌的预后不良和细胞增殖增强

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate the role of signal transduction and activation of transcription 4 (STAT4) in the development and progression of human hepatocellular carcinoma (HCC).METHODS: Recent genetic investigations have identified that a genetic variant of STAT4 is associated with hepatitis B virus (HBV)-related HCC. The level of STAT4 in 90 HCC patients was examined via Western blot and immunohistochemical analyses. The correlation between STAT4 expression and the clinicopathological characteristics of the patients was analyzed. The level of STAT4 expression in the HCC liver tissues was significantly lower than that in the non-HCC liver tissues and correlated with tumor size, histological grade of HCC and serum hepatitis B surface antigen level in HCC patients. The data were statistically analyzed using SPSS. Furthermore, siRNA oligos targeting STAT4 were employed to investigate the influence of STAT4 RNA interference on HCC cell physiology. Based on Cell Counting Kit-8 and flow cytometric assays, we found that depletion of STAT4 expression significantly enhanced the proliferation of L02 cells.RESULTS: STAT4 protein expression was significantly lower in HCC tissues than in normal liver tissues. Immunohistochemistry followed by statistical analysis revealed that the expression of STAT4 negatively correlated with Ki67 expression (r = 0.851; P < 0.05) and positively correlated with maximal tumor size (P < 0.05), HBV (P = 0.012) and histological grade (P < 0.05). Kaplan-Meier analysis revealed significant differences in the survival curves between HCC patients expressing low and high levels of STAT4 and Ki67 (P < 0.05). Based on a multivariate Cox proportional hazard model, STAT4 expression was an independent prognostic indicator for HCC patients who underwent curative resection. In vitro, following the release of L02 cell lines from serum starvation, the expression of STAT4 was downregulated, and transfection of L02 cells with siRNA targeting STAT4 inhibited cell proliferation.CONCLUSION: Our data indicate that STAT4 may inhibit HCC development by modulating HCC cell proliferation.
机译:目的:研究信号转导和转录激活4(STAT4)在人类肝细胞癌(HCC)的发生和发展中的作用。方法:最近的遗传研究发现STAT4的遗传变异与乙型肝炎病毒( HBV)相关的肝癌。通过Western印迹和免疫组化分析检查了90例HCC患者的STAT4水平。分析了STAT4表达与患者临床病理特征之间的相关性。肝癌肝组织中STAT4的表达水平明显低于非肝癌肝组织,且与肿瘤大小,肝癌组织学分级和血清乙肝表面抗原水平相关。使用SPSS对数据进行统计分析。此外,采用靶向STAT4的siRNA寡核苷酸来研究STAT4 RNA干扰对HCC细胞生理的影响。基于Cell Counting Kit-8和流式细胞仪检测,我们发现STAT4表达的减少显着增强了L02细胞的增殖。结果:HCC组织中STAT4蛋白的表达明显低于正常肝组织。免疫组织化学及随后的统计分析表明,STAT4的表达与Ki67表达呈负相关(r = 0.851; P <0.05),与最大肿瘤大小(P <0.05),HBV(P = 0.012)和组织学分级(P <0.05)呈正相关。 0.05)。 Kaplan-Meier分析显示,表达低水平和高水平STAT4和Ki67的HCC患者之间的生存曲线存在显着差异(P <0.05)。基于多元Cox比例风险模型,STAT4表达是接受根治性切除的HCC患者的独立预后指标。在体外,从饥饿状态释放L02细胞系后,STAT4的表达下调,用靶向STAT4的siRNA转染L02细胞可抑制细胞增殖。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号